Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

LEMAITRE VASCULAR INC Director's Dealing 2017

Sep 1, 2017

31708_dirs_2017-09-01_e7e20c96-1bef-4a69-9f3e-745662465994.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: LEMAITRE VASCULAR INC (LMAT)
CIK: 0001158895
Period of Report: 2017-08-30

Reporting Person: Roberts David B (Director, President and Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2017-08-30 Common Stock M 19503 $11.43 Acquired 48108 Direct
2017-08-30 Common Stock M 7180 $14.13 Acquired 55288 Direct
2017-08-30 Common Stock S 26683 $36.6705 Disposed 28605 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2017-08-30 Stock Option (Right to Buy) $11.43 M 19503 Disposed 2022-07-23 Common Stock (19503) Direct
2017-08-30 Stock Option (Right to Buy) $14.13 M 7180 Disposed 2023-07-25 Common Stock (7180) Direct

Footnotes

F1: Represents shares acquired upon exercise of options by the Reporting Person, as reported in Table II.

F2: The price reported in Column 4 is a weighted average price. The transaction was executed in multiple trades ranging from $36.52 to $37.17. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and price at which the transaction was effected.

F3: This option is exercisable and vests over a five-year period at a rate of 20% on the first anniversary of the date listed in the table, and the balance vesting in equal annual installments over the remaining four years.